Treatment of obesity and related disorders

Details for Australian Patent Application No. 2005305036 (hide)

Owner Amylin Pharmaceuticals, Inc.

Inventors Anderson, Christen M.; Roth, Jonathan; Baron, Alain

Agent Freehills

Pub. Number AU-B-2005305036

PCT Pub. Number WO2006/052608

Priority 60/624,357 01.11.04 US

Filing date 1 November 2005

Wipo publication date 18 May 2006

Acceptance publication date 10 March 2011

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

17 May 2007 PCT application entered the National Phase

  PCT publication WO2006/052608 Priority application(s): WO2006/052608

10 March 2011 Application Accepted

  Published as AU-B-2005305036

7 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005305038-Professional matching service

2005305034-Novel functional fluid compositions